mesalamine has been researched along with Psoriasis in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present the case of a woman with Crohn's disease who developed psoriasis after treatment with two anti-TNF- α drugs (infliximab and adalimumab)." | 1.37 | [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis]. ( Bosque López, MJ; Rocamora Durán, V; Royo Escosa, V; Sansó Sureda, A; Sapiña Camaró, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar Yehuda, S | 1 |
| Axlerod, R | 1 |
| Toker, O | 1 |
| Zigman, N | 1 |
| Goren, I | 1 |
| Mourad, V | 1 |
| Lederman, N | 1 |
| Cohen, N | 1 |
| Matz, E | 1 |
| Dushnitzky, D | 1 |
| Gavish, M | 1 |
| Borovsky, N | 1 |
| Schwarts, D | 1 |
| Dotan, I | 1 |
| Turner, D | 1 |
| Sansó Sureda, A | 1 |
| Rocamora Durán, V | 1 |
| Sapiña Camaró, A | 1 |
| Royo Escosa, V | 1 |
| Bosque López, MJ | 1 |
2 other studies available for mesalamine and Psoriasis
| Article | Year |
|---|---|
The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biological Products; Case | 2019 |
[Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanize | 2011 |